SCHEMBL6205217

SCHEMBL6205217

COC(O)Cc1cc(Cl)cc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.39
MDM2 Q00987 1/20 0.34
TSHR P16473 2/20 0.33
PNMT P11086 1/20 0.33
NR3C1 P04150 1/20 0.33
PGR P06401 1/20 0.33
NR3C2 P08235 1/20 0.33
CNR2 P34972 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TACR1 P25103 2/20 0.32
RECQL P46063 1/20 0.32
MAPT P10636 1/20 0.31
GRN P28799 1/20 0.30
SORT1 Q99523 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRB1 P18505 1/20 0.30
HTR3E A5X5Y0 1/20 0.30
HTR3B O95264 1/20 0.30
HTR3A P46098 1/20 0.30
HTR3D Q70Z44 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203638 0.81 PNMT (0.58) IDO1TSHRPNMTRECQLHTR3E
SCHEMBL29889000 0.76 TSHR (0.42) IDO1MDM2TSHRPNMTNR3C1
SCHEMBL6205215 0.75 IDO1 (0.39) IDO1MDM2TSHRPNMTNR3C1
SCHEMBL6203922 0.75 PNMT (0.55) IDO1TSHRPNMTTACR1
SCHEMBL14402602 0.72 NR3C1 (0.40) IDO1MDM2TSHRPNMTNR3C1
SCHEMBL5950554 0.71 TSHR (0.42) IDO1TSHRPNMTNR3C1PGR
SCHEMBL11571104 0.71 TSHR (0.39) IDO1MDM2TSHRPNMTNR3C1
SCHEMBL6203597 0.71 MAOA (0.40) NR3C1L3MBTL1MAPT
SCHEMBL5018736 0.70 PNMT (0.43) IDO1TSHRPNMTNR3C1PGR
SCHEMBL7268862 0.70 LAP3 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed